126 research outputs found
Effect of few-walled carbon nanotube crystallinity on electron field emission property
We discuss the influence of few-walled carbon nanotubes (FWCNTs) treated with nitric acid and/or sulfuric acid on field emission characteristics. FWCNTs/tetraethyl orthosilicate (TEOS) thin film field emitters were fabricated by a spray method using FWCNTs/TEOS sol one-component solution onto indium tin oxide (ITO) glass. After thermal curing, they were found tightly adhered to the ITO glass, and after an activation process by a taping method, numerous FWCNTs were aligned preferentially in the vertical direction. Pristine FWCNT/ TEOS-based field emitters revealed higher current density, lower turn-on field, and a higher field enhancement factor than the oxidized FWCNTs-based field emitters. However, the unstable dispersion of pristine FWCNT in TEOS/N,N-dimethylformamide solution was not applicable to the field emitter fabrication using a spray method. Although the field emitter of nitric acid-treated FWCNT showed slightly lower field emission characteristics, this could be improved by the introduction of metal nanoparticles or resistive layer coating. Thus, we can conclude that our spray method using nitric acid-treated FWCNT could be useful for fabricating a field emitter and offers several advantages compared to previously reported techniques such as chemical vapor deposition and screen printing.ope
Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1β-stimulated fibroblast-like synoviocytes and in rat arthritis models
A Prospective Multi-center Trial of Escherichia coli Extract for the Prophylactic Treatment of Patients with Chronically Recurrent Cystitis
We have assessed the efficacy and safety of Escherichia coli extract (ECE; UroVaxom (R)) which contains active immunostimulating fractions, in the prophylactic treatment of chronically recurrent cystitis. Forty-two patients with more than 2 episodes of cystitis in the proceeding 6 months were treated for 3 months with one capsule daily of ECE and observed for a further 6 months. The primary efficacy criterion was the number of episodes of recurrent cystitis during the 6 months after treatment compared to those during the 6 months before treatment. At the end of the 9-month trial, 34 patients (all women) were eligible for statistical analysis. Their mean age was 56.4 yr (range, 34-75 yr), and they had experienced recurrent urinary tract infections for 7.2 +/- 5.2 yr. The number of recurrences was significantly lower during the 6-month follow-up period than during the 6 months preceding the trial (0.35 vs. 4.26, P<0.001). During the follow-up, 28 (82.4%) patients had no recurrences and 4 (11.8%) had 1 each. In patients who relapsed, ECE alleviated cystitis symptoms, including painful voiding, frequency and urgency. There were no serious adverse events related to the study drug. Our study demonstrates the efficacy and safety of ECE in the prophylactic treatment of chronically recurrent cystitis.Ha US, 2008, INT J ANTIMICROB AG, V31, pS63, DOI 10.1016/j.ijantimicag.2007.07.018LEE SJ, 2008, KOREAN J UROL, V48, P428Krieger JN, 2002, J UROLOGY, V168, P2351, DOI 10.1097/01.ju.0000037620.30988.b2Barnett BJ, 1997, AM J MED SCI, V314, P245Nicolle LE, 1997, INFECT DIS CLIN N AM, V11, P647Baier W, 1997, ARZNEIMITTEL-FORSCH, V47, P980Lettgen B, 1996, CURR THER RES CLIN E, V57, P464AVORN J, 1994, JAMA-J AM MED ASSOC, V271, P751MAGASI P, 1994, EUR UROL, V26, P137SCHULMAN CC, 1993, J UROLOGY, V150, P917JACOBY GA, 1991, NEW ENGL J MED, V324, P601NAUCK M, 1991, INT J EXP CLIN CHEMO, V4, P1SOTOLONGO JR, 1990, J UROLOGY, V143, P979VANPHAM T, 1990, J BIOL RESP MODIF, V9, P231TAMMEN H, 1990, BRIT J UROL, V65, P6HANSSON S, 1989, BRIT MED J, V298, P856HANSSON S, 1989, BRIT MED J, V298, P853WYBRAN J, 1989, IMMUNOPHARM IMMUNOT, V11, P17BOSCH A, 1988, IMMUNOPHARM IMMUNOT, V10, P333TAMMEN H, 1988, UROLOGE, V28, P294BOTTEX C, 1988, INT J IMMUNOTHER, V4, P203FREY C, 1986, UROL INT, V41, P444HAUSER WE, 1982, AM J MED, V72, P711
Pulmonary Hypertension Associated with Use of Phentermine
Weight-control drugs (known as anorexigens) such as fenfluramine have been linked with pulmonary hypertension in previous reports. In our case, a 29 year old woman was admitted for shortness of breath and was diagnosed with pulmonary hypertension. Three months ago, she had been taking phentermine for five weeks. Other factors that might have contributed to the development of pulmonary hypertension were excluded. With treatment, her symptoms improved. This is the first case that can suggest a possible connection between phenermine single medication with pulmonary hypertension. Phentermine has been considered a relatively safe drug to treat obesity, and further investigation is needed to decide the safety and dosage of phentermine
Constrictive Pericarditis Accompanied by Swine-Origin Influenza A (H1N1) Infection
Swine-origin influenza A (H1N1) is caused by a new strain of the influenza virus. The disease has spread rapidly and was declared a pandemic in April, 2009. So far, however, there is a scarcity of information regarding the complications of swine influenza. A report of the disease in the winter of 2009 in the Southern Hemisphere found that the most common manifestations of influenza A virus infection are upper respiratory tract infection and pneumonia. Although there may be an association between fulminant myocarditis and Swine influenza, cardiovascular complications resulting from swine Influenza A infection are exceedingly rare. We report a case of acute constrictive pericarditis in a healthy subject infected by the swine-origin influenza A (H1N1) virus
Percutaneous Cardiopulmonary Support-Supported Percutaneous Coronary Intervention: A Single Center Experience
BACKGROUND AND OBJECTIVES:
Percutaneous cardiopulmonary support (PCPS) has proven to be a valuable technique in high-risk coronary patients undergoing percutaneous coronary intervention (PCI). However, there have been few studies on PCI associated with PCPS in Korea. We summarized our experience with PCPS-supported PCI.
SUBJECTS AND METHODS:
We retrospectively reviewed 19 patients with PCPS-supported PCI between August 2005 and June 2009. PCPS was used as an elective procedure for 10 patients with at least two of the following conditions: left-ventricular ejection fraction <35%, target vessel(s) supplying more than 50% of the viable myocardium, high risk surgical patients, and patients who refused coronary bypass surgery. In the remaining 9 patients PCPS was used as an emergency procedure, to stabilize and even resuscitate patients with acute myocardial infarction and cardiogenic shock, in order to attempt urgent PCI.
RESULTS:
Among the 19 patients who were treated with PCPS-supported PCI, 11 (57.9%) survived and 8 (42.1%) patients did not. ST elevation myocardial infarction with cardiogenic shock was more prevalent in the non-survivors than in the survivors (75% vs. 27.3%, p=0.04). The elective PCPS-supported PCI was practiced more frequently in the survivors than in the non-survivors (72.7% vs. 25%, p=0.04). In the analysis of the event-free survival curve between elective and emergency procedures, there was a significant difference in the survival rate (p=0.025). Among the survivors there were more patients with multi-vessel disease, but a lower Thrombolysis in Myocardial Infarction grade in the culprit lesions was detected in the non-survivors, before PCI. Although we studied high-risk patients, there was no procedure-related mortality.
CONCLUSION:
Our experience suggests that PCPS may be helpful in high risk patients treated with PCI, especially in elective cases. More aggressive and larger scale studies of PCPS should follow
Pre-flight optical test and calibration for the Cosmic Infrared Background ExpeRiment 2 (CIBER-2)
The total integrated emission from galaxies, known as the Extragalactic Background Light (EBL), is an important observable for understanding the history of star formation over the history of the universe. Spatial fluctuations in the infrared EBL as measured by the Cosmic Infrared Background ExpeRiment (CIBER), Spitzer and AKARI exceed the predicted signal from galaxy clustering alone. The CIBER-2 project seeks to extend CIBER observa- tions of the EBL throughout the near infrared into the optical, through measurements above Earth's atmosphere during a suborbital sounding rocket flight. The experiment has a LN2-cooled 28.5 cm Cassegrain telescope along with three optical paths and dichroic beamsplitters, which are used to obtain three wide-field images in six broad spectral bands between 0.5-2.0 μm. The three focal planes also contain linear variable filters (LVFs) which simultaneously take spectra with resolution R=20 across the same range. CIBER-2 is scheduled to y multiple times on a Black Brant IX sounding rocket from White Sands Missile Range in the New Mexico desert. For the first flight, scheduled for early 2021, we have completed a variety of pre-flight optical tests, which we use to make focus adjustments, spectral response measurements, and absolute photometric calibrations. In this paper, we describe the methods behind these tests and present their results for pre-flight performance evaluation. In particular, we present measurements of the PSF for each broad spectral band, along with absolute calibration factors for each band and the LVF. Through monochromator scans, we also measure the spectral responsivity of each LVF as a function of position
Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer
<p>Abstract</p> <p>Background</p> <p>There is increasing evidence that the presence of an ongoing systemic inflammatory response is associated with poor prognosis in patients with advanced cancers. We evaluated the relationships between clinical status, laboratory factors and progression free survival (PFS), and overall survival (OS) in patients with recurrent or metastatic gastric cancer receiving first-line palliative chemotherapy.</p> <p>Methods</p> <p>We reviewed 402 patients with advanced gastric adenocarcinoma who received first-line palliative chemotherapy from June 2004 and December 2009. Various chemotherapy regimens were used. Eastern Cooperative Oncology Group performance status (ECOG PS), C-reactive protein (CRP), albumin, Glasgow prognostic score (GPS), and clinical factors were recorded immediately prior to first-line chemotherapy. Patients with both an elevated CRP (>1.0 mg/dL) and hypoalbuminemia (<3.5 mg/dL) were assigned a GPS of 2. Patients in whom only one of these biochemical abnormalities was present were assigned a GPS of 1, and patients with a normal CRP and albumin were assigned a score of 0. To evaluate the factors that affected PFS and OS, univariate and multivariate analyses were performed.</p> <p>Results</p> <p>According to multivariate analysis, the factors independently associated with PFS were ECOG PS (HR 1.37, 95% CI 1.02-1.84, <it>P </it>= 0.035), bone metastasis (HR 1.74, 95% CI 1.14-2.65, <it>P </it>= 0.009), and CRP elevation (HR 1.64, 95% CI 1.28-2.09, <it>P </it>= 0.001). The factors independently associated with OS were ECOG PS (HR 1.33, 95% CI 1.01-1.76, <it>P </it>= 0.037), bone metastasis (HR 1.61, 95% CI 1.08-2.39, <it>P </it>= 0.017), and GPS ≥ 1 (HR 1.76, 95% CI 1.41-2.19, <it>P </it>= 0.001).</p> <p>Conclusions</p> <p>The results of this study showed that the presence of a systemic inflammatory response as evidenced by the CRP, GPS was significantly associated with shorter PFS and OS in patients with recurrent or metastatic gastric cancer receiving first-line palliative chemotherapy. Bone metastasis and GPS were very useful indicator for survival in patients with recurrent or metastatic gastric cancer receiving palliative chemotherapy.</p
Development of data storage system and GSE for cosmic infrared background experiment 2 (CIBER-2)
Cosmic Infrared Background ExpeRiment-2 (CIBER-2) is an international project to make a rocket-borne measurement of the Cosmic Infrared Background (CIB) using three HAWAII-2RG image sensors. Since the rocket telemetry is unable to downlink all the image data in real time, we adopt an onboard data storage board for each sensor electronics. In this presentation, the development of the data storage board and the Ground Station Electronics (GSE) system for CIBER2 are described. We have fabricated, integrated, and tested all systems and confirmed that all work as expected, and are ready for flight
- …